Quick Answer
MBX Biosciences, Inc. reported Total Assets of $385.14 million for fiscal year 2025.
MBX Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $385.14M | +43.4% |
| 2024 | $268.54M | +219.0% |
| 2023 | $84.18M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $400.08M | +41.7% | +72.8% |
| June 30, 2025 | $231.52M | — | -5.9% |
| March 31, 2025 | $245.93M | — | -8.4% |
| December 31, 2024 | $268.54M | +219.0% | -4.9% |
| September 30, 2024 | $282.40M | — | +235.5% |
| December 31, 2023 | $84.18M | — | — |
- MBX Biosciences, Inc. showed an increase of +43.4% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, MBX Biosciences, Inc.’s total assets has grown by 357.5% (from $84.18 million to $385.14 million).
- The most recent figure is from MBX Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: